High Prevalence of Hyperhomocysteinemia and Asymptomatic Vascular Disease in Siblings of Young Patients With Vascular Disease and Hyperhomocysteinemia

• Published in: Arteriosclerosis, thrombosis, and vascular biology Vol. 17; no. 11; pp. 2655 - 2662
• Main Authors: de Jong, Sylvia C, Stehouwer, Coen D.A, Mackaay, Albert J.C, van den Berg, Michiel, Bulterijs, Ellen J, Visser, Frans C, Bax, Jeroen, Rauwerda, Jan A
• Format: Journal Article
• Language: English
• Published: Philadelphia, PA American Heart Association, Inc 01-11-1997; Hagerstown, MD Lippincott
• Subjects: Adult; Atherosclerosis (general aspects, experimental research); Biological and medical sciences; Blood and lymphatic vessels; Blood Pressure; Cardiology. Vascular system; Carotid Stenosis - diagnostic imaging; Carotid Stenosis - epidemiology; Diabetes Mellitus - epidemiology; Disease Susceptibility; Echocardiography; Exercise Test; Fasting; Female; Homocysteine - blood; Humans; Hypercholesterolemia - epidemiology; Hypertension - epidemiology; Male; Mass Screening; Medical sciences; Methionine - blood; Middle Aged; Multivariate Analysis; Nuclear Family; Prevalence; Risk Factors; Single-Blind Method; Smoking - epidemiology; Vascular Diseases - blood; Vascular Diseases - genetics; Human; Nervous system diseases; Cardiovascular disease; Metabolic diseases; Asymptomatic; Sibling; Enzymopathy; Cerebral disorder; Genetic disease; Vascular disease; Homocystinuria; Central nervous system disease; Atherosclerosis; Risk factor; Age; Aminoacid disorder
• ISSN: 1079-5642; 1524-4636
• DOI: 10.1161/01.ATV.17.11.2655

Hyperhomocysteinemia (HHC) is associated with an increased risk of atherosclerotic vascular disease and may be inherited. Fasting and postmethionine HHC are independent risk factors that overlap to a limited extent. To study the familial occurrence of HHC, we investigated the prevalence of HHC (both fasting and after methionine) among 450 siblings of 167 consecutive young patients with vascular disease and postmethionine HHC. Furthermore, all subjects with postmethionine HHC (n = 125) were invited for noninvasive vascular testing; 101 (80.8%) agreed. Of those with a normal postmethionine plasma level (n = 325), we randomly selected 73 subjects for further studies; 53 agreed (72.6%). Thus, a total of 154 siblings underwent ultrasonography of the carotid arteries, measurement of ankle-brachial pressure indices at rest and after a treadmill exercise test, and exercise electrocardiographic stress testing. We observed HHC after methionine, fasting, or both, in 27.8% (95% CI, 23.7 to 31.9), 11.1% (CI, 8.2 to 14.0) and 8.7% (CI, 6.1 to 11.3) of the siblings. Abnormal peripheral, coronary, or carotid artery tests were observed in 35.7% (CI, 28.1 to 43.3), 7.1% (CI, 3.0 to 11.2), and 7.1% (CI, 3.0 to 11.2). Univariate and multivariate analyses revealed weak evidence of a relationship with homocysteine levels.In conclusion, we found a high prevalence of HHC and asymptomatic vascular disease in siblings of young patients with vascular (mainly peripheral arterial) disease and HHC.Our data raise the possibility that homocysteine does not play a major role in the early, asymptomatic phases of vascular disease, at least among siblings of young patients with vascular disease. (Arterioscler Thromb Vasc Biol. 1997;17:2655-2662.)